Our Products and Services

Oranoxis™ specializes in the development and manufacture of quantitative and qualitative immunoassays for drugs of abuse, food safety, environmental pollutants, and therapeutic drug monitoring. Our products meet high standards of accuracy, sensitivity, and precision due to our proprietary lateral flow platform technologies in addition to our strict quality management system. Please see our full product list, or click on the following product categories below for more specific details.

DOAicon ELISAicon reagenticon collectoricon

Oranoxis™ provides contract conjugation and nanoparticle technology services, and contract services for immunoassay development and manufacturing. We also provide consulting services for immunoassay R&D, quality control, and troubleshooting. Please see our full list of services for more information.

Please contact us for product and/or service inquiries, price quotations, and product distribution interests.

News and Events

November 2017
Oranoxis™ is ready for Medica 2017! Looking forward to meeting new clients and making valuable business connections. See you November 13th to 16th!

August 2017
The team at Oranoxis™ enjoyed AACC Conference 2017!

August 2016
Oranoxis™ is ready for AACC Conference in Philadelphia! Come see us at booth #4079 August 2-4

April 2016
Oranoxis™ unveils new rapid test reader at DATIA 2016 Conference in Las Vegas, NV.

March 2015
Oranoxis™ completes notification of all on-site drugs of abuse testing devices and receives new CE mark for Oral-AQ™, ToxWipe-Oral™, ToxWipe-Oral™ K2, and ToxStick K2™.

January 2015
Oranoxis™ launches ToxWipe-Oral™ K2 and ToxStick K2™ for on-site drugs of abuse testing of K2/synthetic cannabinoids. ToxWipe-Oral™ K2 is one of the first rapid test devices on the market capable of detecting K2/synthetic cannabinoids in oral fluid, and ToxStick K2™ detects major K2/synthetic cannabinoids in urine with high sensitivity.

August 2014
Oranoxis™ introduces a new product line, ToxWipe-Oral™, for on-site drugs of abuse testing. ToxWipe-Oral™ is designed to enhance convenience and ease of use for roadside and on-site preliminary testing, and allows for a more rapid sample collection by requiring a smaller volume of oral fluid.

April 2012
Oranoxis™ successfully receives ISO 13485:2003 certification by NSF International.

Quality Commitment

Oranoxis™ is committed to providing high quality products and services. Our quality management system enforces strict quality control and quality assurance practices to ensure the exceptional quality of our products and services.

Oranoxis™ is a FDA registered medical device manufacturer and is ISO 13485:2003 certified by NSF International.

We comply with current Good Manufacturing Practices (cGMP)/Quality System Regulation (QSR). All of our products are Made in the USA and CE marked for proof of quality comformance with European IVD Directive 98/79/EC.

Additionally, our oral fluid sample collection device is composed of medical grade materials that are "Generally Recognized As Safe" (GRAS) by the Food and Drug Administration (FDA).